Diphtheria vs Streptococcal Tonsillitis: Clinical Differentiation and Management
The critical distinguishing feature is the presence of a gray, adherent pseudomembrane in diphtheria that extends beyond the tonsils into the nasopharynx or larynx, while streptococcal tonsillitis presents with tonsillar exudate without membrane formation and typically includes fever, pharyngeal erythema, and tender anterior cervical lymphadenopathy.
Key Clinical Distinctions
Diphtheria (Corynebacterium diphtheriae)
The hallmark of respiratory diphtheria is a gray-colored pseudomembrane firmly adherent to the mucosa lining the nasopharynx, tonsils, or larynx 1. This membrane can extend into the trachea-bronchial tree causing life-threatening airway obstruction 2.
Critical systemic features include:
- Toxin-mediated cardiac complications (myocarditis)
- Neurologic complications (neuropathy)
- Bull neck appearance from massive cervical lymphadenopathy
- Low-grade fever (often less prominent than in streptococcal infection)
- Median incubation period of 1.4 days 3
The pseudomembrane bleeds when attempts are made to remove it—a key differentiating feature 2.
Streptococcal Tonsillitis (Group A Streptococcus)
Clinical features alone cannot reliably discriminate between GAS and viral pharyngitis, except when overt viral features are present 4. However, streptococcal infection typically presents with:
- Tonsillar exudate (not a true membrane)
- High fever
- Pharyngeal erythema
- Tender anterior cervical lymphadenopathy
- Absence of cough, rhinorrhea, hoarseness, or oral ulcers (these suggest viral etiology) 4
Diagnostic Approach
For Suspected Streptococcal Tonsillitis
Use the Centor or McIsaac scoring system to estimate probability of GAS infection 5, 6:
- If score ≥3: Perform rapid antigen detection test (RADT) and/or throat culture 4
- In children and adolescents: Negative RADT must be backed up by throat culture 4
- In adults: Back-up culture not routinely needed due to low incidence and minimal rheumatic fever risk 4
Do not perform:
- Anti-streptococcal antibody titers (ASLO)—these reflect past, not current infection 4, 5
- Routine blood tests for acute tonsillitis 5
For Suspected Diphtheria
Clinical diagnosis must be confirmed by:
- Bacterial culture from throat swab
- Identification of toxigenic Corynebacterium diphtheriae strains
- Enzymatic and toxin detection tests 2
Critical caveat: In the post-vaccination era, diphtheria is extremely rare in developed countries (only 13 cases reported in the US from 1996-2016) 1, making streptococcal pharyngitis far more likely. However, diphtheria remains endemic in parts of Asia and Africa, with over 80% of global cases from India and Indonesia 7.
Treatment Recommendations
Streptococcal Tonsillitis
First-line treatment: Penicillin or amoxicillin for 10 days 4. This narrow-spectrum approach is preferred based on proven efficacy, safety, low cost, and the fact that penicillin-resistant GAS has never been documented 4.
For penicillin-allergic patients:
- First-generation cephalosporin for 10 days (if not anaphylactically sensitive) 4
- Clindamycin for 10 days 4
- Clarithromycin for 10 days 4
- Azithromycin for 5 days 4
Adjunctive therapy:
- Acetaminophen or NSAIDs for symptom control 4
- Avoid aspirin in children (Reye's syndrome risk) 4
- Corticosteroids are not recommended 4
Diphtheria
Immediate treatment requires:
- Diphtheria antitoxin (must be given early to prevent toxin-mediated complications) 2, 3
- Antimicrobial therapy (antibiotics alone are insufficient) 2
- Isolation (essential for transmission control) 3
The combination of antitoxin and antibiotics is critical—antibiotics reduce infection duration but cannot limit morbidity without antitoxin 3.
Critical Pitfalls to Avoid
Do not rely on clinical features alone for GAS diagnosis—testing is mandatory except when viral features are obvious 4
Do not test children <3 years old for routine pharyngitis—GAS pharyngitis and rheumatic fever are uncommon in this age group 4, 8
Do not perform follow-up cultures after treatment unless special circumstances exist 4
Do not treat asymptomatic household contacts of GAS patients 4
In suspected diphtheria, do not delay antitoxin while awaiting culture results—mortality increases with delayed treatment 2
Consider vaccination status and travel history—diphtheria immunity wanes without decennial boosters, and only 60% of the US population has protective antibody levels 1
The key clinical decision point is recognizing the adherent gray pseudomembrane of diphtheria versus the removable exudate of streptococcal infection, combined with systemic toxicity patterns and epidemiological context 7, 2.